Just Published

Clinical Overview

July 17, 2026

An overview from Andrew Van Der Vaart, MD, on who responds to transcranial magnetic stimulation for depression, how it works, and how the standard, theta-burst, and SAINT protocols differ.
news

July 16, 2026

Two psychedelics show early GAD trial signals—DT120 and psilocybin—but no agent is approved for anxiety. Interpreting evidence by stage, not label, matters
JCP
Original Research ▶ Video

July 8, 2026

Findings suggest that active VNS reduces suicidal ideation (SI) and potentially induces SI remission among participants with chronic TRD and baseline SI.
news

July 7, 2026

DT120 (lysergide), a 5-HT2A agonist, eased GAD anxiety in trial. Beyond SSRIs/SNRIs, psychoplastogens offer new remission path.
news

July 7, 2026

GAD affects 10% of US adults yet remission stalls on SSRIs/SNRIs. New real-world data and psychedelic trials reveal the persistent treatment gap.
Where Autoantibodies Strike in Anti-NMDAR Encephalitis
news

January 26, 2026

A new study shows that antibodies in anti-NMDAR encephalitis target exposed hotspots on NMDA receptors, explaining synaptic disruption.

Explore
By Topic

View all topics
Addiction Anxiety Bipolar Disorder Depression (MDD) Movement Disorders Neurology Obsessive-Compulsive and Related Disorders Psychopharmacology Schizophrenia/Schizoaffective Disorders Tardive Dyskinesia

Front of Mind News

Weekly Mind Reader: When Antidepressants Fail

Recent Features

Image shows a syringe below a question about schizophrenia relapse prevention; The Psychiatrist.com logo appears at the bottom.
Figure: Promotional graphic announces a consensus report on Xanomeline-Trospium use in practice, highlighting JCP branding.
Figure: Flyer shows an adult cradling a newborn, promoting a University of Arizona event on mental health for women and children.
Figure shows a hand holding a vial and syringe above report title on PK of aripiprazole LAIs as described in JCP.

The Journal of Clinical Psychiatry

The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals. Now featuring The JCP Podcast: conversations with experts exploring the research shaping clinical care.  

EXPLORE JCP
JCP
Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?
ASCP Corner

January 26, 2026

This article will familiarize US clinicians with amisulpride’s history and data, and the rationale behind development of LB-102, an N-methylated analogue of amisulpride.
,
JCP
Urological Commentary on Ketamine-Associated Uropathy
Letter to the Editor

January 26, 2026

The author comments on a recent article reviewing ketamine-associated uropathy in therapeutic and nontherapeutic settings.

Explore Special Sections from JCP

Focus on Childhood and Adolescent Mental Health Early Career Psychiatrists Focus on Geriatric Psychiatry Focus on Psychosis Focus on Psychotherapy Focus on Suicide Focus on Women’s Mental Health

The Primary Care Companion for CNS Disorders

The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.

View PCC Articles
PCC
Basal Ganglia Stroke With Lower Motor Neuron Features
Case Report

January 22, 2026

A 60-year-old man exhibited left-sided toe walking and right-sided weakness despite previous history of left sided basal ganglia stroke, challenging the notion that adult toe walking is a hallmark…
, , , et al
PCC
Benign Ethnic Neutropenia and Clozapine
Case Report

January 22, 2026

This case highlights the importance of recognizing benign ethnic neutropenia to prevent unnecessary clozapine discontinuation.
, , , et al
CME Logo

Recent CME Institute Activities

ASCP - American Society of Clinical Psychopharmacology logo

Read articles from ASCP Corner

ASCP Corner

Consensus Report on XT Use in Practice

Read the full report

Subscribe to read
more articles

Subscribe